J. Cuzick

5.2k total citations · 1 hit paper
40 papers, 2.1k citations indexed

About

J. Cuzick is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, J. Cuzick has authored 40 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 17 papers in Genetics and 12 papers in Cancer Research. Recurrent topics in J. Cuzick's work include Estrogen and related hormone effects (17 papers), Breast Cancer Treatment Studies (9 papers) and Cervical Cancer and HPV Research (7 papers). J. Cuzick is often cited by papers focused on Estrogen and related hormone effects (17 papers), Breast Cancer Treatment Studies (9 papers) and Cervical Cancer and HPV Research (7 papers). J. Cuzick collaborates with scholars based in United Kingdom, United States and Italy. J. Cuzick's co-authors include Lesley Fallowfield, Katie Thirlaway, Jeremy R. Jass, Wendy Atkin, H J R Bussey, I P Todd, B C Morson, J M A Northover, M. Kaufmann and Laurence Ambroisine and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

J. Cuzick

39 papers receiving 2.0k citations

Hit Papers

The grading of rectal cancer: historical perspectives and... 1986 2026 1999 2012 1986 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Cuzick United Kingdom 15 1.2k 812 695 375 314 40 2.1k
A. De Matteis Italy 21 1.2k 1.0× 809 1.0× 533 0.8× 174 0.5× 356 1.1× 58 2.1k
C.-M. Rudenstam Sweden 18 1.2k 1.0× 746 0.9× 437 0.6× 248 0.7× 304 1.0× 28 1.7k
Eduardo R. Pajon United States 15 1.9k 1.6× 1.8k 2.2× 929 1.3× 729 1.9× 445 1.4× 22 3.4k
Caroline Lohrisch Canada 23 1.3k 1.1× 934 1.2× 410 0.6× 242 0.6× 408 1.3× 80 2.1k
Jurij Lindtner Switzerland 25 1.7k 1.4× 1.5k 1.8× 446 0.6× 755 2.0× 572 1.8× 34 2.6k
Geraldine Walsh United Kingdom 17 1.6k 1.3× 1.4k 1.8× 819 1.2× 341 0.9× 573 1.8× 29 2.4k
N Sacks United Kingdom 18 976 0.8× 792 1.0× 551 0.8× 390 1.0× 346 1.1× 28 1.8k
Edward Azavedo Sweden 25 1.0k 0.9× 666 0.8× 360 0.5× 522 1.4× 385 1.2× 57 2.1k
K Holli Finland 28 1.8k 1.5× 1.3k 1.7× 772 1.1× 468 1.2× 380 1.2× 47 3.0k
Manuela Rabaglio Switzerland 22 1.2k 1.0× 819 1.0× 779 1.1× 168 0.4× 589 1.9× 83 2.0k

Countries citing papers authored by J. Cuzick

Since Specialization
Citations

This map shows the geographic impact of J. Cuzick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Cuzick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Cuzick more than expected).

Fields of papers citing papers by J. Cuzick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Cuzick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Cuzick. The network helps show where J. Cuzick may publish in the future.

Co-authorship network of co-authors of J. Cuzick

This figure shows the co-authorship network connecting the top 25 collaborators of J. Cuzick. A scholar is included among the top collaborators of J. Cuzick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Cuzick. J. Cuzick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Šestak, Ivana, Mitch Dowsett, Dennis C. Sgroi, et al.. (2013). Comparison of Five Different Scores for the Prediction of Late Recurrence for Oestrogen Receptor-Positive Breast Cancer. Annals of Oncology. 24. iii29–iii29. 4 indexed citations
2.
Ronco, Guglielmo, Annibale Biggeri, Massimo Confortini, et al.. (2012). Health Technology assessment Report: Ricerca del dna di papillomavirus umano (HPV) come test primario per lo screening dei precursori del cancro del collo dell'utero.. Pure Amsterdam UMC. 36. 1–72. 2 indexed citations
3.
Šestak, Ivana, J. Cuzick, Mitch Dowsett, et al.. (2011). P2-12-09: Prediction of Residual Risk of Recurrence after 5 Years of Follow-Up by Clinicopathologic Variables and 4 IHC Markers: A TransATAC Study.. Cancer Research. 71(24_Supplement). P2–12. 1 indexed citations
5.
Berney, Daniel M., Anuradha Gopalan, Sakunthala C. Kudahetti, et al.. (2008). Ki-67 is an independent predictor of outcome in conservatively treated clinically localised prostate cancer. Modern Pathology. 21. 1 indexed citations
6.
Ronco, Guglielmo, et al.. (2008). Accuracy of Liquid Based Versus Conventional Cytology. Journal of Lower Genital Tract Disease. 12(3). 254–254. 6 indexed citations
7.
Sherrill, Beth, et al.. (2008). Disease progression as a predictor of overall survival in metastatic breast cancer: a meta-analysis. European Journal of Cancer Supplements. 6(7). 216–216. 2 indexed citations
8.
Cuzick, J., Peter Sasieni, & Anthony Howell. (2006). Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?. British Journal of Cancer. 94(4). 460–464. 43 indexed citations
9.
Warwick, Jane, Elizabeth Pinney, Ruth Warren, et al.. (2003). Breast density and breast cancer risk factors in a high-risk population. The Breast. 12(1). 10–16. 29 indexed citations
10.
Locker, Gershon Y., et al.. (2002). Breast surgery in the ATAC trial: women from the United States are more likely to have mastectomy.. UCL Discovery (University College London). 6 indexed citations
11.
Kaufmann, M., W. Jonat, R.W. Blarney, et al.. (2002). Updated survival results from the Zebra trial.. Breast Cancer Research and Treatment. 76. 2 indexed citations
12.
Cuzick, J. & Anthony Howell. (2000). A brief review of the breast cancer prevention trials. European Journal of Cancer. 36. 51–53. 3 indexed citations
13.
Cuzick, J.. (1998). Continuation of the International Breast Cancer Intervention Study (IBIS).. PubMed. 34(11). 1647–8. 7 indexed citations
14.
Thirlaway, Katie, Lesley Fallowfield, & J. Cuzick. (1996). The Sexual Activity Questionnaire: A measure of women's sexual functioning. Quality of Life Research. 5(1). 81–90. 264 indexed citations
15.
Cuzick, J.. (1995). Methodologic Issues in the Chemoprevention of Breast Cancer1. PubMed. 16(1). 111–120. 4 indexed citations
16.
Szarewski, Anne, et al.. (1991). The Use of Cervicography in a Primary Screening Service. Obstetrical & Gynecological Survey. 46(9). 632–633. 2 indexed citations
17.
Cuzick, J., et al.. (1990). Anal cancer and marital status. British Journal of Cancer. 62(2). 286–288. 20 indexed citations
18.
Szarewski, Anne, et al.. (1990). A comparison of four cytological sampling techniques in a genitourinary medicine clinic.. Sexually Transmitted Infections. 66(6). 439–443. 13 indexed citations
19.
Fentiman, Ian S., Frances R. Balkwill, J. Cuzick, J.L. Hayward, & R.D. Rubens. (1987). A trial of human alpha interferon as an adjuvant agent in breast cancer after loco-regional recurrence.. PubMed. 13(5). 425–8. 20 indexed citations
20.
Léonard, Renaud, I. C. M. Maclennan, Y. Cheng Smart, R I Vanhegan, & J. Cuzick. (1979). Light chain isotype‐associated suppression of normal plasma cell numbers in patients with multiple myeloma. International Journal of Cancer. 24(4). 385–393. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026